SUBSTRATES OF HAGEMAN FACTOR : I. Isolation and Characterization of Human Factor XI (PTA) and Inhibition of the Activated Enzyme by α1-Antitrypsin
暂无分享,去创建一个
[1] P. Lee,et al. Preparation, Characterization, and Activation of a Highly Purified Factor XI: Evidence that a Hitherto Unrecognized Plasma Activity Participates in the Interaction of Factors XI and XII , 1974, British journal of haematology.
[2] A. Kaplan,et al. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. , 1974, The Journal of clinical investigation.
[3] R. Rosenberg,et al. Anticoagulant Action of Heparin , 1973, Nature.
[4] K. Wuepper. PREKALLIKREIN DEFICIENCY IN MAN , 1973, The Journal of experimental medicine.
[5] K. Wuepper,et al. ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES , 1973, The Journal of experimental medicine.
[6] O. Ratnoff,et al. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin. , 1973, The Journal of clinical investigation.
[7] I. Liener,et al. The purification of human serum 1 -antitrypsin by affinity chromatography on concanavalin A. , 1973, Biochemical and biophysical research communications.
[8] K. Austen,et al. THE FIBRINOLYTIC PATHWAY OF HUMAN PLASMA , 1972, Journal of Experimental Medicine.
[9] O. Ratnoff,et al. The inhibitory properties of plasma against activated plasma thromboplastin antecedent (factor XIa) in hereditary angioneurotic edema. , 1972, The Journal of laboratory and clinical medicine.
[10] O. Ratnoff,et al. Partial purification and some properties of a plasma inhibitor of activated plasma thromboplastin antecedent (factor XI). , 1972, The Journal of laboratory and clinical medicine.
[11] O. Ratnoff. Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI). , 1972, The Journal of laboratory and clinical medicine.
[12] D. McConnell. Inhibitors of kallikrein in human plasma. , 1972, The Journal of clinical investigation.
[13] K. Austen,et al. A PREALBUMIN ACTIVATOR OF PREKALLIKREIN III. APPEARANCE OF CHEMOTACTIC ACTIVITY FOR HUMAN NEUTROPHILS BY THE CONVERSION OF HUMAN PREKALLIKREIN TO KALLIKREIN , 1972 .
[14] P. Harpel. Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor. , 1971, The Journal of clinical investigation.
[15] K. Austen,et al. A PREALBUMIN ACTIVATOR OF PREKALLIKREIN , 1971, The Journal of experimental medicine.
[16] D. Deutsch,et al. Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.
[17] C. Forbes,et al. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. , 1970, The Journal of laboratory and clinical medicine.
[18] Kaplan Ap,et al. A pre-albumin activator of prekallikrein. , 1970, Journal of immunology.
[19] K. Weber,et al. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.
[20] B. C. Hummel,et al. Quantitative enzymic assay of human plasminogen and plasmin with azocasein as substrate , 1965 .
[21] J. Niemetz,et al. A NORMAL INHIBITOR OF THE BLOOD COAGULATION CONTACT REACTION PRODUCT. , 1965, Blood.
[22] O. Ratnoff,et al. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. , 1961, The Journal of clinical investigation.